SAKAR HEALTHCARE
Back to Cashflow Statement
|
SAKAR HEALTHCARE Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-0.16 Cr | ₹0.37 Cr | ₹0.06 Cr | ₹-0.05 Cr | ₹-0.22 Cr |
What is the latest Net Cash Inflow / Outflow ratio of SAKAR HEALTHCARE ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹-0.16 Cr |
| Mar2024 | ₹0.37 Cr |
| Mar2023 | ₹0.06 Cr |
| Mar2022 | ₹-0.05 Cr |
| Mar2021 | ₹-0.22 Cr |
How is Net Cash Inflow / Outflow of SAKAR HEALTHCARE Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹-0.16 Cr | Negative | |
| Mar2024 | ₹0.37 Cr | 481.25 | |
| Mar2023 | ₹0.06 Cr | Positive | |
| Mar2022 | ₹-0.05 Cr | Negative | |
| Mar2021 | ₹-0.22 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of SAKAR HEALTHCARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SAKAR HEALTHCARE | ₹1,163.4 Cr | 0.6% | 36.2% | 100.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹420,531.0 Cr | 1.3% | 8.9% | 6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,989.0 Cr | 2.4% | 6% | 12.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,936.0 Cr | -0.6% | 9.4% | 44.1% | Stock Analytics | |
| CIPLA | ₹109,200.0 Cr | 1.9% | 2% | -8.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,057.0 Cr | -0.4% | 9.5% | 10.5% | Stock Analytics | |
SAKAR HEALTHCARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SAKAR HEALTHCARE | 0.6% |
36.2% |
100.3% |
| SENSEX | -3.7% |
-2.5% |
6.5% |
You may also like the below Video Courses